Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993

Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993–2020

Published:2021-04 Issue: Volume:322 Page:61-66
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Leren Trond P.^ORCID,Bogsrud Martin Prøven

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment;Rader;J. Clin. Invest.,2003

2. Familial hypercholesterolemia;Goldstein,2001

3. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017

4. Introduction: structure and metabolism of plasma lipoproteins;Havel,2001

5. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia;Goldstein;J. Clin. Invest.,1973

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The singular French PCSK9-p.Ser127Arg gain-of-function variant: a significant player in cholesterol levels from a 775-year-old common ancestor;Atherosclerosis;2024-09

2. Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levels;Frontiers in Cardiovascular Medicine;2024-07-26

3. Overcoming the real and imagined barriers to cholesterol screening in pediatrics;Journal of Clinical Lipidology;2024-05

4. Neglected Mendelian causes of stroke in adult Chinese patients who had an ischaemic stroke or transient ischaemic attack;Stroke and Vascular Neurology;2023-07-26

5. A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK’s NHS long term plan;PLOS Global Public Health;2023-04-25